Dermata Therapeutics Inc.

NASDAQ: DRMAW · Real-Time Price · USD
0.02
0.00 (29.03%)
At close: Jun 09, 2025, 3:06 PM

Dermata Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-12.29M -7.79M -9.61M -7.9M
Depreciation & Amortization
n/a n/a n/a 14.13K
Stock-Based Compensation
657.65K 522.08K 930.33K 1.91M
Other Working Capital
575.38K 494.35K -135.03K -121.42K
Other Non-Cash Items
n/a 369.33K 930.33K 14.13K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
466.86K 494.35K -153.58K 289.55K
Operating Cash Flow
-11.16M -6.41M -8.83M -5.69M
Capital Expenditures
n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
n/a n/a n/a n/a
Debt Repayment
n/a n/a n/a 1.01M
Common Stock Repurchased
-828 -40 n/a -1M
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
1.11K 187.00 287.00 n/a
Financial Cash Flow
6.89M 7.61M 4.28M 15.96M
Net Cash Flow
-4.28M 1.2M -4.56M 10.27M
Free Cash Flow
-11.16M -6.41M -8.83M -5.69M